177Lu-PSMA-I&T
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for 177Lu-PSMA-I&T, covering 2019-12-06 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer [Phase 3]